Fundraising Fox

Pardes Biosciences

San Francisco, US · Founded 2020 · 2 employees · Public · 3 known investors

pardesbio.com ↗

Pardes Biosciences develops oral medications designed to treat and prevent viral infections, including COVID-19.

BiotechHealthtechTherapeuticsin /pardesbio/@ycombinator

Founders & leadership· Y Combinator alumni (S20)

Uri Lopatin

Uri Lopatin inFounder/CEO

Investors · 3

Y CombinatorMountain View · $500K – $500K

Foresite CapitalreportedWest Hollywood

Khosla VenturesreportedMenlo Park

In the news

Pardes Biosciences nets $199 million in COVID-19 pill race - Los Angeles Timeslatimes.com · 2021
Pardes Biosciences Debuts as a Publicly Traded Company Focused on Oral Antiviral Therapies to Potentially Treat and Prevent COVID-19globenewswire.com · 2021